{
    "2020-06-23": [
        [
            {
                "time": "2020-06-23",
                "original_text": "布局肿瘤免疫治疗方向热门靶点 贝达药业与美国Agenu斯达成合作",
                "features": {
                    "keywords": [
                        "肿瘤免疫治疗",
                        "贝达药业",
                        "Agenu斯",
                        "合作"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "医药生物行业日报：新冠疫苗获批临床",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "引进两抗体项目 贝达药业拓展肿瘤免疫治疗布局",
                "features": {
                    "keywords": [
                        "抗体项目",
                        "贝达药业",
                        "肿瘤免疫治疗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "龙虎榜机构新动向：净买入13股 净卖出11股",
                "features": {
                    "keywords": [
                        "龙虎榜",
                        "机构",
                        "净买入",
                        "净卖出"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "贝达药业等91股股价创历史新高",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股价",
                        "历史新高"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "贝达药业加速涨停再创新高，两机构买入超7000万元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "涨停",
                        "机构买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "3500万美元合作Agenu斯公司，贝达药业加入PD-1战局",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "Agenu斯",
                        "PD-1",
                        "合作"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "A股收盘综述：市场再现“喝酒吃药”，创业板指8连升",
                "features": {
                    "keywords": [
                        "A股",
                        "喝酒吃药",
                        "创业板指",
                        "连升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-23",
                "original_text": "快讯：基因测序板块午后集体拉升1.76%，马应龙、贝达药业涨停",
                "features": {
                    "keywords": [
                        "基因测序",
                        "贝达药业",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}